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Affective immunology: where emotions and 
the immune response converge
Fulvio D’Acquisto, MSc, MRes, PhD
The emotional-immune response 
continuum: the case for research 
in affective immunology
 Studies over the last few decades have provided 
sufficient evidence for similarities and overlaps be-
tween the immune and emotional responses. The ma-
jority of living beings use both systems to adjust dynam-
ically to the ever-changing conditions of the external 
environment. Both systems can either be protective for 
the body if kept under control or detrimental to it when 
they are in disarray. Despite the vast body of knowledge 
we have gathered on the links between these two sys-
tems, there have been very few attempts to move this 
area of research from bench to bedside.1-9 This might be 
due to many causes, including the perceived impression 
that the world of immunology and that of psychology 
or psychiatry are completely different, if not polar op-
posites. 
 One of the main aims of this review is to help over-
come this skepticism and to highlight the importance 
of these similarities in clinical settings. Indeed, I firmly 
believe that a deeper understanding of the cellular and 
molecular links between the emotional and immuno-
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Affect and emotion are defined as “an essential part of 
the process of an organism’s interaction with stimuli.” 
Similar to affect, the immune response is the “tool” 
the body uses to interact with the external environ-
ment. Thanks to the emotional and immunological re-
sponse, we learn to distinguish between what we like 
and what we do not like, to counteract a broad range 
of challenges, and to adjust to the environment we are 
living in. Recent compelling evidence has shown that 
the emotional and immunological systems share more 
than a similarity of functions. This review article will 
discuss the crosstalk between these two systems and 
the need for a new scientific area of research called 
affective immunology. Research in this field will allow 
a better understanding and appreciation of the immu-
nological basis of mental disorders and the emotional 
side of immune diseases.  
© 2017, AICH – Servier Research Group Dialogues Clin Neurosci. 2017;19:9-18.
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logical systems can lead to significant advances in trans-
lational research. I call this new field of research “af-
fective immunology” (www.affectiveimmunology.com) 
to distinguish it from the broader field of psychoneu-
roimmunology and to specifically connect the immune 
response to emotions and behavior and vice versa. 
 What is affective immunology and what are its aims? 
First and foremost, affective immunology is a framework 
of research based on two fundamental assumptions: (i) 
the immune and emotional systems mirror each other; 
(ii) both the immunological and emotional responses are 
dynamic and continuously changing. The first assumption 
is based on a large body of both clinical and experimen-
tal evidence showing an increased incidence of emotional 
disorders in patients suffering from immune diseases1,10-14 
and an increased susceptibility to immune diseases in pa-
tients suffering from mental disorders.15-18 These links and 
connections have been extensively discussed in several 
review articles,1-3,6,18-22 including our own.23-25 The second 
assumption is based on new and emerging ideas that both 
the emotional and immune systems are highly “plas-
tic.”26-33 The term plasticity has been used to indicate the 
ability to change and adjust continuously depending on 
the external factors or living conditions. 
 From the translational point of view, plasticity is a 
very interesting feature of this area of research. In fact, 
unlike genetic mutations or inherited predisposition to 
diseases that cannot be modified, we can exploit plas-
ticity to bring about therapeutic changes in a relatively 
easy way. Adopting a healthier diet,34,35 developing a 
stable emotional intelligence,36-38 improving one’s so-
cioeconomic conditions,39 and ceasing unhealthy habits 
such as drinking or smoking40 have all been reported to 
be beneficial for both the emotional and immunological 
responses. However, how all these diverse approaches 
specifically exert their therapeutic effects is far from be-
ing clear.23 
 This article will provide a brief overview of the com-
plexity (and fascination) of the crosstalk between the 
emotional and immunological systems. More specifi-
cally, the aim is to show how the reductionist approach 
of just linking “being happy” or “being stressed” with 
“feeling well” or “feeling sick,” is neither useful nor sci-
entifically robust. It will begin with a discussion on how 
established and subject-specific factors, such as per-
sonality type or certain immune repertoires, can pre-
dispose to the development of immune and emotional 
disorders. Next, we will try to convince the reader that 
the duration of what one could call an immunological 
or emotional challenge is a key factor in determining 
its impact on the emotional or immunological response. 
Last but not least, the translational potential of these 
findings will be discussed, hoping that this will inspire 
future scientists to see the therapeutic promise of affec-
tive immunology. 
Carl Jung and Sigmund Freud were 
immunologists, but they did not know it
The beginning of the 19th century saw a great many 
changes in society worldwide, with some aspects being 
catastrophic and others revolutionary and life changing. 
Many unique personalities populated this historical pe-
riod. In the field of psychology, Sigmund Freud and Carl 
Gustav Jung emerged as the founders of new landmark 
theories that changed the way we think about ourselves 
in the context of society. For Sigmund Freud, daily living 
was the result of a compromise between what one re-
ally wants and desires (the id) and what society expects 
from us (the superego).41 Carl Jung was very interested 
in patterns of daily living, and he defined two different 
attitudes called extroversion and introversion.42 The fo-
cus of extroverted personalities is mainly “the external 
object,” eg, the outside worlds. Conversely, introverted 
personalities show as an attitude characterized by a “fo-
cus on one’s inner psychic activity.”43
 Translating these ideas into the field of immunology, 
one would say that innate immune cells are “extrovert-
ed,” as they are always looking out for something new 
coming from the outside world and continuously engage 
with the external environment. Macrophages patrol tis-
sues or organs, and monocytes and neutrophils quickly 
migrate to the site of infection during inflammation. 
Adaptive immune cells have an “introverted personal-
ity” because of their increased concern about creating 
an inner experience of life events, especially if they have 
been deleterious for the host. This is what immunologists 
call immunological memory.44 Innate and adaptive im-
mune cells both work toward trying to adjust the body 
to accommodate the requests of the external (the super-
ego) and the internal (the id) environments. 
 If immune cells have different “personalities” just 
like human beings do, one might wonder if there is a 
correlation between psychological and immunological 
personality. A recent meta-analysis investigated wheth-
er the five basic personality traits—often referred to as 
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the “Big 5” personality traits45 (openness to experience, 
conscientiousness, extraversion, agreeableness, and neu-
roticism)—have specifi c immunological features or de-
fi ned susceptibility to immune disorders. The study has 
shown a consistent association between conscientious-
ness and a reduced infl ammatory response, as judged by 
the lower level of C-reactive protein (CRP) in subjects 
with this personality trait.46 Ground-breaking studies 
by Steve Cole and colleagues have further supported 
this concept and shown a specifi c association between 
the Big 5 and unique patterns of gene expression in 
whole blood. Consistent with the other investigations, 
the study by Cole and colleagues showed that conscien-
tiousness was associated with a reduced expression of 
proinfl ammatory factors.47
 Besides the evidence provided by these studies, the 
idea that certain emotional traits are correlated with 
specifi c immune responses should come as no surprise. 
In fact, the two systems develop almost side by side, and 
when one becomes defective, the other one often does 
the same; ie, one mirrors the other, as mentioned above. 
If we just focus on the development of immunological 
and emotional competence, it is well known that both 
systems are subjected to a great deal of changes during 
childhood and until adulthood.48-50 Both systems learn 
to adjust to challenges of the external environment 
through vaccinations (lessons for the immune system) 
or through the development of a healthy emotional in-
telligence (lessons for the emotional system).51 Looking 
at the other side of the coin, eg, the dysfunctions rather 
than the development, both immune and emotional 
dysfunctions are known to have a high incidence in the 
age range from 30 to 50. Autoimmune diseases, such as 
rheumatoid arthritis, peak between 30 and 5552; Sjögren 
syndrome is more prevalent in subjects aged 45 to 6053; 
and patients suffering from multiple sclerosis usually 
develop symptoms when they are between 20 and 40 
years old.54 In a similar way, the highest incidence for 
the two main classes of mental diseases, namely anxiety 
disorders and mood disorders, occurs in the populations 
aged between 25 to 53 and 25 to 45, respectively.55 
Acute and chronic emotional disturbances 
and their impact on the immune system
In the previous paragraphs, some evidence has been pro-
vided for a high degree of similarity between the emo-
tional and immune systems, both in healthy and diseased 
conditions. What are the implications of these similari-
ties, and why should we care about them? The answer 
to these questions should be readily clear the moment 
we imagine the immune and emotional responses as 
two connected reservoirs in equilibrium with each oth-
er (Figure 1). In normal or “healthy” conditions, chal-
lenges of different origins, such as pathogens or emo-
tional traumas, are buffered in an equal proportion by 
the emotional and immunological systems. One classical 
example of this is when an infection becomes systemic. 
The body activates the fever response, which helps the 
immune system to clear the pathogen.56 In parallel to 
this, the host also experiences the sickness response,57 
eg, “a coordinated set of adaptive behavioral changes” 
featured by “lethargy, depression, anxiety, malaise, loss of 
appetite, sleepiness, hyperalgesia.” The combined action 
of the emotional and immunological reactions induced 
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 Figure 1.  Schematic representation of the link between the emotional 
and immunological systems in healthy and diseased con-
ditions. In a normal basal state (top left panel), the emo-
tional and immunological responses are linked with each 
other in equilibrium. In healthy conditions (top right panel), 
pathogens of different nature, changes in environmental 
conditions, and signifi cant life events prompt an adaptive 
response that helps the host deal with these challenges. In 
patients suffering from emotional (bottom left panel) or im-
munological (bottom right panel) disorders, the same chal-
lenges cause an exacerbated or dysfunctional compensatory 
immune or emotional response, respectively. 
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by the infection has the ultimate aim of stopping the host 
from increasing the chances of worsening his/her condi-
tion. This is achieved by limiting the host’s activity and 
interaction with other living beings, thus limiting expo-
sure to potential further infection. 
 What happens when the system is not in equilibrium 
and either the immunological or emotional response 
becomes dysfunctional? Several factors should be tak-
en into consideration when answering this question, the 
first of which being the duration of the emotional “chal-
lenge” or immunological stimulus. When we consider 
emotional stimuli of short duration, for example, acute, 
short-term psychological stress, studies have shown 
that these cause a selective and timely orchestrated im-
mune response characterized by an increase in natural 
killer (NK) cells in the circulation.58-60 Downregulation 
of signaling sensors of the innate immune system, such 
as Toll-like receptor pathways, has also been reported.61 
These effects seem to be linked to the release of cat-
echolamines and their effect on leukocytosis.60,62-64
 A number of studies have further explored the ef-
fects of acute stress on the mobilization of NK cells and 
have revealed that other similar types of cells, such as 
CD56+ NK T cells65 and γδ T cells,66,67 also respond to 
this stimulus. This is a rather interesting observation 
considering that these cells belong to a relatively mi-
nor category of immune cells called “unconventional” 
T cells.68 Their name derives from the fact that they are 
not considered adaptive immune cells recognizing a 
specific antigen, but are more like innate cells recogniz-
ing patterns of antigens. Indeed, unconventional T cells 
react quite quickly to stimulation68 and recognize non-
specific antigens, such as lipids, small-molecule metabo-
lites, and modified peptides. Thus, it seems that the im-
mune system is capable of distinguishing between acute 
stress and classical infectious pathogens by activating a 
specific class of immune cells. In addition, the recruit-
ment of unconventional T cells in circulation by acute 
stress seems to suggest that these events might trigger 
the generation of antigenic small molecules, the nature 
of which it is still to be determined. This is a fascinating 
hypothesis, as the identification of such antigens would 
make conceivable the creation of a vaccine for people 
at high risk of developing emotional disorders, some-
thing that has already been suggested.69,70
 Do acute positive emotions exert an immunomodu-
latory effect through NK and unconventional T cells? 
In studies that have considered mirthful laughter to be 
an acute positive emotional stimulus, it is interesting to 
note that such a stimulus did not increase the number 
of these types of cells but rather improved their biologi-
cal activity.71-74 Indeed, NK cells of healthy subjects that 
have watched humor videos for 1 hour showed a signifi-
cant increase in the killing activity of these cells 12 hours 
after exposure to the video.75 Laughing or positive hu-
mor is not the only effective stimulus for NK cells. In-
deed, healthy subjects asked to watch a film featuring 
their favorite person, such as a love interest or favorite 
actor/actress (positive film), showed similar increased 
NK-cell activity to those who had been “treated” with 
an emotionally neutral film (control film).76 In another 
study, volunteers were asked to follow a mindfulness-
based stress reduction (MBSR) program for 8 weeks 
(20 to 30 minutes of meditation a day at home, 6 days a 
week). Most strikingly, only those subjects reporting an 
improvement in their emotional well-being showed an 
increased NK cytotoxic activity, whereas such changes 
were not observed in those reporting no improvement .77 
 What happens in chronic conditions? For example, 
what happens if the emotional and immunological chal-
lenges are present for a long period of time or have 
become persistent? The scientific literature in this field 
is vast and expands to other areas of research, includ-
ing pain,78 neurodegeneration,79 and vascular diseases.80 
These studies are difficult to analyze, as it is challenging 
to establish if the activation of the immune system, for 
instance, is the actual driver and cause of disease or the 
result of the emotional response being elicited. If we just 
focus on cardiovascular diseases, for instance, there is 
now clear evidence that pathologies like atherosclerosis 
and even stroke have an immunological and emotional 
basis.81-83 Indeed, in an elegant commentary by Pariante 
and Mondelli on a named series entitled “Psychologi-
cal Risk Factors and Immune System Involvement in 
Cardiovascular Disease,” the authors highlighted how 
there is now enough scientific evidence “to put an end 
to an era in which the heart and the mind were consid-
ered to be separate entities in which the responses of 
one system did not affect the other.”84 As one would 
expect, inflammation and activation of the immune re-
sponse were the recurrent themes among all the stud-
ies included in the series. Putting all this together, it is 
clear that from an experimental and therapeutic point 
of view, understanding how chronic dysfunctions of the 
immune or emotional system influence another system 
is far from being simple. Is it that chronic stress causes 
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depression, which then causes inflammation, which is in 
turn responsible for the increased risk of cardiovascu-
lar disorders or is it that constant inflammation causes 
depression and ultimately an increased risk of develop-
ing cardiovascular disease? Where is the beginning and 
where the end of this vicious circle?
 A possible solution to this dilemma might come from 
a slight change of approach. Most of the studies currently 
in the literature focus on the effects of chronic negative 
emotions on the immune system. These can range from 
divorce and marital problems85,86 to bereavement87-89 and 
loneliness.39,90,91 Surprisingly, however, very little has been 
published on the effect that positive emotional states 
have on the immune response. Of course, one might ar-
gue that it is easier to study disease conditions and chal-
lenging to study “wellness,” especially if there is no such 
condition as “being well”; indeed, there are almost no 
biomarkers that would indicate whether someone has 
a strong immune resilience or competence. At best, sci-
entists have so far measured a reduction in known bio-
markers of “negative emotional states,” including corti-
sol, catecholamine, and various cytokines, such as tumor 
necrosis factor α (TNF-α), interleukin (IL)-1β and IL-6. 
Knowing the gene signature of positive emotional states 
could be beneficial from several points of view. Firstly, 
it would provide new therapeutic avenues to explore, 
aiming to improve the immunological state of patients 
suffering from chronic mental disorders. Secondly, it 
would allow us to assess whether a dysfunction in these 
pathways could be a leading cause behind the cascade 
of complications that occur later, for example, immune 
defects and associated comorbidities, such as cardiovas-
cular disorders and neurodegenerative diseases. 
 We tried this approach in two of our recent studies 
where we “administered” a positive emotional state to 
mice for 2 weeks. Mice were either subjected to a daily 
session of 1 hour of massage-like stroking92 or housed in 
an enriched environment.93 Both experimental systems 
have been described to improve the welfare of experi-
mental animals94-99 and can be considered as an artificial 
experimental surrogate of caressing or of changing your 
living conditions (such as during holidays for instance) 
in humans. Our results have shown that both treatments 
have a significant impact on the immune system. First, 
stroking caused a marked reduction in the noradren-
ergic tone of lymphoid organs. Noradrenaline acts as 
an immunosuppressant to the immune system, and the 
reduction in its levels in the thymus caused a significant 
increase in the number of T cells in circulation. Con-
sequently, stroked mice showed an improved response 
to the immunosuppressive effects of exogenously ad-
ministered hydrocortisone, providing experimental evi-
dence for an improved immune resilience. 
 A similar finding was observed with mice housed 
in the enriched environment. Microarray analysis of 
CD4 T cells showed a discrete and unique pattern of 
genes that were specifically modulated in enriched cells. 
Most interestingly, these genes included the following: 
SOCS3, a member of the suppressor of cytokine sig-
naling family that regulates CD8+ T-cell proliferation 
through inhibition of IL-6 and IL-27; several regula-
tors of CD4+ CD25− T-cell and regulatory T-cell (Treg) 
differentiation; Nr4a2 (nuclear receptor subfamily 4, 
group A, member 2); and Trib1 (tribbles pseudokinase 
1). Trib1 acts upon Foxp3 (forkhead box P3; also known 
as scurfin) cobinding with the transcription factor to 
enhance its Treg-promoting function. Most strikingly, 
enriched T cells acquired a unique phenotype during 
differentiation in effector cells and produced higher 
levels of IL-10 and IL-17 than did CD4 T cells of mice 
housed in standard conditions. This new phenotype has 
been called Th17reg, and it has been proposed to play 
a key role in the resolution of inflammation,100 eg, the 
active process whereby the immune system “shuts itself 
up” and turns down the inflammatory response.101 Al-
though the validity of these observations needs to be 
verified in vivo and in humans, these results suggest that 
improving living conditions is translated at the level of 
the immune system into an increased ability to mount 
an effective and protective immune response. 
Acute and chronic immunological 
disturbances and their impact on the 
emotional response
Very little is known about the effects of transient or 
acute dysfunction of the immune system and the effect 
on emotional well-being. Most of the data available in 
this respect concern the effects of the acute adminis-
tration of immunosuppressant drugs. Studies have in-
deed shown that the therapeutic immunosuppression 
brought about by calcineurin inhibitors is often limited 
by the side effects that these drugs have on the emo-
tional response.102 These effects have been especially 
noted in patients subjected to transplantations and un-
dergoing cycles of immunosuppressive pharmacologi-
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cal therapies. Indeed, the depressive-like behavior of 
solid-organ recipients affects up to 60% of this popula-
tion and is independently associated with both mortal-
ity and de novo malignancy after transplantation.103
 Unlike acute immune suppression, several studies 
in experimental animals have shown that chronic de-
fects in the immune system have a dramatic impact on 
the emotional response. Immunodeficient mice, such 
as severe combined immunodeficiency (SCID) mice 
or recombinase-activating gene (RAG)-1-/- mice, have 
been shown to have an impaired learning and memo-
ry,104 as well as an increased basal level of anxiety-like 
behavior.105 Microarray analysis of the gene expression 
profile of the whole brain of RAG-1-/- mice showed a 
significant difference from that of the wild-type control. 
Most of the genes correlated with neurodegeneration 
or emotional disorders. Most interestingly, these chang-
es were partially but significantly reversed in OT-II/
RAG-1-/- mice, eg, mice that selectively had CD4+ but 
not CD8+ T cells, thus suggesting that CD4+ T cells exert 
a homeostatic control over the correct tuning of genes 
in the brain.105 Along these lines, in another study per-
formed in RAG-2-/- mice (immunocompromised mice 
similar to RAG-1-/-), the absence of adaptive immune 
cells was associated with emotional deficits during in-
flammation. Indeed, these authors also suggested that 
the depressive states associated with several diseases 
might be mediated, at least in part, by an impaired lym-
phocyte response.
 The mechanisms behind these effects are fascinat-
ing. Seminal work by Jonathan Kipnis and colleagues 
has revealed functional lymphatic vessels lining the du-
ral sinuses that express all of the molecular hallmarks 
of lymphatic endothelial cells. These vessels are able 
to provide brain access both to fluid and immune cells 
from the cerebrospinal fluid.106 The discovery of these 
“T-cell gateways to the brain” has allowed the same 
researcher to show that meningeal T cells produce in-
terferon γ as a key mediator that regulates social be-
havior.107 These findings are consistent with previous 
research in humans that has shown that eudaimonic 
well-being is associated with a decreased expression 
of proinflammatory genes and increased expression of 
genes involved in antibody synthesis and type I inter-
feron response.108 
 Several human studies have confirmed the link be-
tween a state of immunosuppression and the develop-
ment of mental disorders. The most common condition 
that can be taken as an example is acquired immuno-
deficiency syndrome (AIDS).109,110 Most interestingly, 
and in line with what has been mentioned above, stud-
ies have found a correlation between lower CD4 counts 
and the emergence of emotional disorders in individu-
als who have recently acquired human immunodefi-
ciency virus (HIV).111 Similar increased incidence of 
mental disorders after or before the diagnosis of im-
mune disease has been reported for systemic lupus ery-
thematosus,112 multiple sclerosis,113,114 and rheumatoid 
arthritis.115,116 However, the role of T cells or other im-
mune cells in the regulation of the emotional response 
in these patients has not been explored as yet. 
 As I have discussed the effects of positive emo-
tions on the immune response, one might wonder what 
would be the effect of an improved immune system on 
the emotional response. Surprisingly, little is known in 
the clinic about the potential of boosting the immune 
system to improve the emotional well-being of patients 
suffering from immune diseases. This is probably linked 
to the fact that we do not really know what the best ap-
proaches are for improving the fitness and resilience of 
the immune system, let alone their postulated effects 
on the emotional response. Yet, there is some indirect 
evidence that supports this idea. In line with our investi-
gation on mice, studies on both children and adults with 
HIV have shown that massage therapy can increase the 
blood cell count of CD4+ cells and result in an improved 
emotional state.117-120 There are other ways to increase 
the number of T cells in the body. One such example 
is the administration of IL-7, a cytokine that enhances 
CD4+ T-cell numbers. Studies on experimental models 
of HIV infections, such as simian immunodeficiency 
virus (SIV)-infected monkeys, have shown that like 
massage, IL-7 is effective in increasing the number of 
CD4+ T cells in these animals.121 It would be interesting 
to investigate if such therapy also improves emotional 
state and whether this approach can be used in humans. 
This is an interesting idea considering that recent stud-
ies have shown a correlation between major depressive 
disorder and lower levels of IL-7.122 
Perspectives
Where do we go from here? The translational value of 
research in the field of affective immunology is solid 
enough to justify new clinical trials for combined thera-
pies targeting the emotional and immunological sys-
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tems. These will undoubtedly be a great opportunity to 
find new therapeutic weapons for psychiatrists, rheuma-
tologists, and clinicians dealing with immune and emo-
tional disorders. However, this would also be a unique 
opportunity for basic scientists, as understanding the 
mechanisms by which this combined approach works 
would significantly shift the way we currently look at 
immune and emotional disorders. 
 Regarding the immune and inflammatory response, 
the biggest challenge for the future is to understand 
how different life events can permanently “mark” im-
mune cells and make them more prone to develop an 
exacerbated immune response.123-125 Research in this 
field should aim at systematically dissecting how differ-
ent social and emotional conditions specifically influ-
ence the immune system. As explored in this article, it 
is indeed very likely that different adverse life events—
eg, social isolation, physical abuse, and bereavement—
might have their own “gene signature” and hence spe-
cific effects on the immune system.
 Regarding emotional disorders, more studies are 
needed to explore what I would call the “peripheral 
control of emotional behavior.” The advancement of 
technologies for the study of brain functions, such as 
the ever more popular functional magnetic resonance 
imaging (fMRI),126,127 has helped the field of neurosci-
ence expand exponentially in a very short period. And 
yet, whereas an enormous number of studies has tried 
to establish areas of the brain that correlate to specific 
emotions or mental disorders, evidence is emerging that 
the gut is an essential organ in the control of emotional 
behavior.128-130 I have provided a few examples of how 
immune cells regulate emotional behavior. However, 
there are other examples of cells or therapies that can 
act as emotional modulators by changing, for instance, 
the composition of blood. One such example is eryth-
ropoietin—the hormone that stimulates the production 
of red blood cells; erythropoietin is a novel treatment 
for a wide range of mental disorders from depression to 
cognitive dysfunctions.131-133 Similarly, it would be inter-
esting to test the idea that changing blood composition 
by altering the number of specific immune cells might 
provide an alternative way to treat emotional disorders 
or dysfunctional personalities. 
 Besides all these considerations for the future, I 
think that establishing the field of affective immunol-
ogy might be useful for reevaluating a large number of 
failed clinical trials for new therapies for immune and 
emotional disorders. Despite the scientific literature 
that has been cited in this and other articles, there are 
no trials for immunomodulatory drugs that take into 
consideration the emotional state of the enrolled pa-
tients. Similarly, there are no trials for mental disorders 
that assess the immune repertoire of recruited patients. 
Therefore, one might wonder if those trials that have 
failed could have had an entirely different outcome if 
the participants were stratified according to their social 
and economical conditions, their personality, emotional 
well-being, or even blood type. There is indeed recent 
evidence suggesting a correlation between the ABO 
blood group and personality traits.134 
 Regardless of the validity of the hypothesis and 
ideas presented in this article, I hope that the readers 
of Dialogues in Clinical Neuroscience will be convinced 
that there is a need to look at immune and emotional 
diseases in a different way. This new approach would 
consider the “whole” of the patient, from his/her im-
mune phenotype to his/her personality, environment, 
and life-style, essential in order to prevent basic experi-
mental scientists and clinicians ending up like the old 
blind men in the Jain parable135 below (reproduced, in 
slightly modified form, courtesy of Jain World). 
Once upon a time, there lived six blind men in a village. One 
day the villagers told them, “Hey, there is an elephant in the 
village today.”
They had no idea what an elephant was. They decided, 
“Even though we would not be able to see it, let us go and 
feel it anyway.” All of them went to where the elephant was. 
Every one of them touched the elephant. 
“Hey, the elephant is a pillar,” said the first man, who 
touched his leg.
“Oh, no! it is like a rope,” said the second man, who touched 
the tail.
“Oh, no! it is like a thick branch of a tree,” said the third 
man, who touched the trunk of the elephant.
“It is like a big hand fan” said the fourth man, who touched 
the ear of the elephant.
“It is like a huge wall,” said the fifth man, who touched the 
belly of the elephant.
“It is like a solid pipe,” Said the sixth man, who touched the 
tusk of the elephant.
They began to argue about the elephant and every one of 
them insisted that he was right. It looked as if they were 
getting agitated. A wise man was passing by and he saw this. 
He stopped and asked them, “What is the matter?” They 
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said, “We cannot agree to what the elephant is like.” Each 
one of them told what he thought the elephant was like. The 
wise man calmly explained to them, “All of you are right. 
The reason every one of you is telling it differently because 
each one of you touched a different part of the elephant. So, 
actually the elephant has all the features that each of you 
mentioned.” o
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La inmunología afectiva: la convergencia de las 
emociones y de la respuesta inmune
Afecto y emoción son definidos como “una parte esen-
cial del proceso de interacción de un organismo con un 
estímulo”. Similar al afecto, la respuesta inmune es la 
“herramienta” que emplea el cuerpo para interactuar 
con el ambiente externo. Gracias a la respuesta emo-
cional e inmune, aprendemos a distinguir entre lo que 
queremos y no queremos, a contrarrestar una amplia 
gama de desafíos, y a adaptarnos con el ambiente don-
de estamos viviendo. Evidencias recientes y convincen-
tes han mostrado que los sistemas emocional e inmuno-
lógico comparten más de una semejanza de funciones. 
Este artículo de revisión discutirá las alteraciones de la 
comunicación entre estos sistemas y la necesidad de una 
nueva área de investigación científica denominada in-
munología afectiva. La investigación en este campo per-
mitirá una mejor comprensión y apreciación de las bases 
inmunológicas de los trastornos mentales y del aspecto 
emocional de las enfermedades inmunes.     
L’immunologie affective : la convergence des 
émotions et de la réponse immunitaire
L’affect et l’émotion se définissent comme « une part es-
sentielle du processus d’interaction d’un organisme avec 
les stimuli ». Similaire à l’affect, la réponse immunitaire 
est « l’outil » utilisé par le corps pour interagir avec l’en-
vironnement extérieur. Grâce aux réponses émotion-
nelle et immunologique, nous apprenons à distinguer 
ce que nous aimons de ce que nous n’aimons pas, pour 
affronter un large éventail de défis, et pour nous adap-
ter à l’environnement dans lequel nous vivons. Des don-
nées récentes ont montré que les systèmes émotionnels 
et immunologiques partagent plus qu’une similarité de 
fonctions. Cet article de synthèse analyse les interac-
tions entre ces deux systèmes et la nécessité de définir 
un nouveau domaine de recherche appelé immunologie 
affective. La recherche dans ce domaine permettra une 
meilleure compréhension et une meilleure appréciation 
de la base immunologique des troubles mentaux et du 
côté émotionnel des maladies immunitaires. 
